Neoadjuvant Chemotherapy Combined with Breast-Conserving Surgery in the Treatment of Triple-Negative Breast Cancer

Table 4

Comparison of immune function between two groups of patients.

Group		CD3+ (%)		CD4+ (%)		CD8+ (%)
		Before treatment	After treatment	Before treatment	After treatment	Before treatment	After treatment
Observation group	50
Study group	50
		0.413	25.514	0.222	14.669	0.088	7.189
		0.681	≤0.001	0.825	≤0.001	0.930	≤0.001